pCDH-EF1-mVenus-p27K− Citations (6)
Originally described in: Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.Correia AL, Guimaraes JC, Auf der Maur P, De Silva D, Trefny MP, Okamoto R, Bruno S, Schmidt A, Mertz K, Volkmann K, Terracciano L, Zippelius A, Vetter M, Kurzeder C, Weber WP, Bentires-Alj M Nature. 2021 Jun;594(7864):566-571. doi: 10.1038/s41586-021-03614-z. Epub 2021 Jun 2. PubMed Journal
Articles Citing pCDH-EF1-mVenus-p27K−
| Articles |
|---|
| The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin alpha6 mRNA splicing. Mukhopadhyay D, Goel HL, Xiong C, Goel S, Kumar A, Li R, Zhu LJ, Clark JL, Brehm MA, Mercurio AM. Cell Rep. 2023 Nov 28;42(11):113347. doi: 10.1016/j.celrep.2023.113347. Epub 2023 Nov 1. PubMed |
| Ferritinophagy mediates adaptive resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Wang H, Hu Q, Chen Y, Huang X, Feng Y, Shi Y, Li R, Yin X, Song X, Liang Y, Zhang T, Xu L, Dong G, Jiang F. Nat Commun. 2024 May 17;15(1):4195. doi: 10.1038/s41467-024-48433-8. PubMed |
| Acetate drives ovarian cancer quiescence via ACSS2-mediated acetyl-CoA production. Sharrow AC, Megill E, Chen AJ, Farooqi A, McGonigal S, Hempel N, Snyder NW, Buckanovich RJ, Aird KM. bioRxiv [Preprint]. 2024 Jul 14:2024.07.12.603313. doi: 10.1101/2024.07.12.603313. PubMed |
| Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition. Collura JL, Lei KC, Chandra M, Kervarrec T, Park HJ, Dalkoohi M, Becker JC, Chang Y, Moore PS, Shuda M. Proc Natl Acad Sci U S A. 2025 Dec 30;122(52):e2516667122. doi: 10.1073/pnas.2516667122. Epub 2025 Dec 24. PubMed |
| Therapy-induced cholesterol biosynthesis drives lung cancer dormancy and drug resistance. Zhao Y, Zhou Y, Pan L, Tian GG, Huang HY, Tang S, Lu M, Zhou Z, Zhang P, Chen L, Zhang L, Hu L, Ji H. J Clin Invest. 2026 Apr 15;136(8):e191735. doi: 10.1172/JCI191735. eCollection 2026 Apr 15. PubMed |
| Melatonin-inspired hybrid spheroids accelerate intestinal repair via YAP-driven fetal reprogramming. Seo Y, Ahn JS, Nguyen NN, Lee HS, Lee Y, Kim SH, Yu JH, Yang JW, Park HJ, Lee H, Shin TH, Lee BC, Sung ES, Lee JH, Kim WK, Oh JM, Lee D, Kim YH, Jeong JH, Kim HS. Asian J Pharm Sci. 2026 Aug;21(4):101176. doi: 10.1016/j.ajps.2026.101176. Epub 2026 Jun 20. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.